Pledges and contributions
Aidspan has officially launched a new data analysis tool designed to provide comprehensive information about historical and current pledges and contributions to the Global Fund.
With less than four weeks to go to the replenishment conference in Washington on 2–3 December, the focus is on countries that have not yet announced their pledges for the Fourth Replenishment.
France has announced that it will contribute € 1.08 billion ($1.4 billion) to the Global Fund for the Fourth Replenishment period (2014–2016). That works out to about $467 million a year. This approximately the same as the amount France pledged for the Third Replenishment (2011–2013).
The Foreign Minister of France, Laurent Fabius, has told civil society representatives that France will not reduce its future contributions to the Global Fund. Mr Fabius met with representatives of AIDES, Coalition Plus, Sidaction and Act-Up Paris on 30 April.
“If we don’t seize this moment, we will be dealing with these diseases for generations,” Global Fund Executive Director Mark Dybul told his audience at the Preparatory Meeting of the Global Fund Fourth Replenishment.
President Barack Obama has asked the US Congress to allocate $1.65 billion for the Global Fund in the budget for fiscal year 2014. If approved, this would appear to constitute the first tranche of the US pledge to the Global Fund for the 2014–2016 replenishment period. (In the US, the 2014 fiscal year runs from 1 October 2013 to 30 September 2014.)
As of 31 December of 2012, donors had pledged $10.4 billion for the 2011–2013 replenishment period. This is a 13% increase over the $9.2 billion pledged at the actual replenishment conference in October 2010.
The difference comes primarily from pledges made following the New York conference. A group of donors, including Belgium, Netherlands, Saudi Arabia and Sweden, announced their pledges after the conference.
Global Fund Executive Director Mark Dybul says that the disease split for the funding allocated to early and interim applicants in the transition phase of the new funding model (NFM) should not be viewed in isolation, but rather in the context of all funding for 2013–2014.